Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

Literature DB >> 21744037

Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology.

A Debourgogne, S de Hoog, A Lozniewski, M Machouart.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2011 PMID： 21744037 DOI： 10.1007/s10096-011-1323-x

Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN： 0934-9723 Impact factor: 3.267

× No keyword cloud information.

14 in total

1. In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.

Authors: Niki I Paphitou; Luis Ostrosky-Zeichner; Victor L Paetznick; Jose R Rodriguez; Enuo Chen; John H Rex
Journal: Antimicrob Agents Chemother Date: 2002-10 Impact factor: 5.191

2. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.

Authors: Olivier Lortholary; Gaelle Obenga; Pinaki Biswas; Denis Caillot; Elisabeth Chachaty; Anne-Lise Bienvenu; Muriel Cornet; John Greene; Raoul Herbrecht; Claire Lacroix; Frédéric Grenouillet; Issam Raad; Karine Sitbon; Peter Troke
Journal: Antimicrob Agents Chemother Date: 2010-07-12 Impact factor: 5.191

3. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.

Authors: A Szekely; E M Johnson; D W Warnock
Journal: J Clin Microbiol Date: 1999-05 Impact factor: 5.948

4. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.

Authors: Marcela Campo; Russell E Lewis; Dimitrios P Kontoyiannis
Journal: J Infect Date: 2010-02-04 Impact factor: 6.072

5. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods.

Authors: Naureen J Iqbal; Angeline Boey; Benjamin J Park; Mary E Brandt
Journal: Diagn Microbiol Infect Dis Date: 2008-08-15 Impact factor: 2.803

6. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

Authors: Manuel Cuenca-Estrella; Alicia Gomez-Lopez; Emilia Mellado; Maria J Buitrago; Araceli Monzon; Juan Luis Rodriguez-Tudela
Journal: Antimicrob Agents Chemother Date: 2006-03 Impact factor: 5.191

7. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China.

Authors: Lixin Xie; Hualei Zhai; Jing Zhao; Shiying Sun; Weiyun Shi; Xiaoguang Dong
Journal: Am J Ophthalmol Date: 2008-06-11 Impact factor: 5.258

8. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies.

Authors: Ana Espinel-Ingroff; Elizabeth Johnson; Hans Hockey; Peter Troke
Journal: J Antimicrob Chemother Date: 2008-01-25 Impact factor: 5.790

9. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.

Authors: Ana Alastruey-Izquierdo; Manuel Cuenca-Estrella; Araceli Monzón; Emilia Mellado; Juan Luís Rodríguez-Tudela
Journal: J Antimicrob Chemother Date: 2008-02-08 Impact factor: 5.790

Review 10. Fusarium infections in immunocompromised patients.

Authors: Marcio Nucci; Elias Anaissie
Journal: Clin Microbiol Rev Date: 2007-10 Impact factor: 26.132

9 in total

1. In Vitro Susceptibility of Fusarium to Isavuconazole.

Authors: A Broutin; J Bigot; Y Senghor; A Moreno-Sabater; J Guitard; C Hennequin
Journal: Antimicrob Agents Chemother Date: 2020-01-27 Impact factor: 5.191

2. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

Authors: Abdullah M S Al-Hatmi; Anne-Cécile Normand; Stephane Ranque; Renaud Piarroux; G Sybren de Hoog; Joseph Meletiadis; Jacques F Meis
Journal: Antimicrob Agents Chemother Date: 2016-12-27 Impact factor: 5.191

Review 3. Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.

Authors: R Araujo; M Oliveira; A Amorim; B Sampaio-Maia
Journal: Eur J Clin Microbiol Infect Dis Date: 2015-04-18 Impact factor: 3.267

4. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.

Authors: A M Tortorano; A Prigitano; M C Esposto; V Arsic Arsenijevic; J Kolarovic; D Ivanovic; L Paripovic; L Klingspor; I Nordøy; P Hamal; S Arikan Akdagli; C Ossi; A Grancini; C Cavanna; G Lo Cascio; C Scarparo; A Candoni; M Caira; M Drogari Apiranthitou
Journal: Eur J Clin Microbiol Infect Dis Date: 2014-05-03 Impact factor: 3.267

5. CYP51 Mutations in the Fusarium solani Species Complex: First Clue to Understand the Low Susceptibility to Azoles of the Genus Fusarium.

Authors: Pierre Vermeulen; Arnaud Gruez; Anne-Lyse Babin; Jean-Pol Frippiat; Marie Machouart; Anne Debourgogne
Journal: J Fungi (Basel) Date: 2022-05-20

6. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.

Authors: Prajna Lalitha; Catherine Q Sun; N Venkatesh Prajna; Rajarathinam Karpagam; Manoharan Geetha; Kieran S O'Brien; Vicky Cevallos; Stephen D McLeod; Nisha R Acharya; Thomas M Lietman
Journal: Am J Ophthalmol Date: 2013-10-22 Impact factor: 5.258